Press release
On-Body Drug Delivery Devices Market is projected to reach US$ 82.74 billion by 2033 | Coherus BioSciences Inc, Tandem Diabetes Care Inc, Battelle, Stevanato Group, NOVO Engineering
On-Body Drug Delivery Devices Market - DataM Intelligence
DataM Intelligence's On-Body Drug Delivery Devices Market report offers in-depth insights into the latest market trends, potential growth areas, and evolving industry challenges. Focused on delivering practical and strategic intelligence, DataM Intelligence equips businesses with the knowledge they need to make confident, forward-thinking decisions. Through a blend of qualitative and quantitative research approaches, the firm produces detailed reports that support clients in understanding complex market forces, identifying new opportunities, and achieving long-term growth in a rapidly changing global environment.
Download your exclusive sample report today: (corporate email gets priority access): https://datamintelligence.com/download-sample/on-body-drug-delivery-devices-market?sg
On-Body Drug Delivery Devices Market Overview 2025:
On-body drug delivery devices (OBDDs) are innovative medical technologies designed to administer medications particularly biologics subcutaneously while remaining attached to the patient's body. Typically worn as a patch, these devices are engineered to deliver high-molecular-weight drugs, such as monoclonal antibodies, with precision in both dosage and timing. Their primary function is to provide a controlled and consistent drug delivery experience, enhancing therapeutic outcomes while promoting patient adherence.
One of the key benefits of OBDDs is the ability to facilitate self-administration in non-clinical settings, significantly reducing the need for frequent hospital visits and needle-based interventions. This is especially beneficial for patients managing long-term conditions like cancer, diabetes, and autoimmune disorders.
The growing prevalence of such chronic illnesses is a major driver behind the rising adoption of on-body drug delivery systems. As the demand for consistent and patient-friendly medication solutions increases, these devices offer a convenient and reliable alternative. In addition, advances in wearable technology and drug delivery mechanisms have led to more intuitive, comfortable, and efficient designs further encouraging uptake among patients and healthcare providers alike.
On-Body Drug Delivery Devices Industry Dynamics:
Rising Demand Fuels Growth in the On-Body Drug Delivery Devices Market
The global market for on-body drug delivery devices (OBDDs) is poised for substantial growth, driven by rising demand linked to the increasing burden of chronic diseases, rapid technological advancements, and the introduction of next-generation products.
The surge in chronic health conditions such as diabetes, cardiovascular diseases, and cancer is a primary factor contributing to the widespread adoption of OBDDs. These conditions often require long-term, precise, and often complex treatment regimens, which on-body systems are well-equipped to support. By enabling patients to self-administer medications at home, OBDDs improve convenience, reduce hospital visits, and promote treatment adherence. For example, data from the American College of Cardiology Foundation highlights that high systolic blood pressure is a leading contributor to cardiovascular disease, with a global burden of 2,564.9 age-standardized DALYs per 100,000 population underscoring the urgent need for efficient drug management strategies.
In parallel, ongoing innovation in wearable drug delivery technology is enhancing the appeal and functionality of these devices. Modern systems such as smart injectors and wearable infusion pumps-are now capable of delivering controlled and extended-release formulations with high precision. In addition to drug administration, many devices incorporate advanced features such as dose tracking, digital connectivity, and real-time monitoring, which empower patients and clinicians to manage treatment regimens more effectively. As these technologies evolve, they are reshaping how chronic diseases are treated and driving consistent growth across the OBDD market.
Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/on-body-drug-delivery-devices-market?sg
Strategic Key Players Driving the On-Body Drug Delivery Devices Market: BD, Gerresheimer AG, NOVO Engineering, West Pharmaceutical Services, Inc., Enable Injections, Stevanato Group, LTS Lohmann Therapie-Systeme AG, Coherus BioSciences, Inc., Tandem Diabetes Care, Inc, Battelle.
Research Methodology:
The global On-Body Drug Delivery Devices Market report utilizes a thorough research methodology that combines both primary and secondary data sources to deliver a well-rounded market assessment. This structured approach carefully examines a wide range of factors that influence the industry, such as regulatory policies, government initiatives, current market dynamics, competitive landscape, historical trends, and present market standing. It also considers technological advancements, emerging developments across sectors, market fluctuations, future growth potential, possible obstacles, and key strategic challenges encountered by market players.
Segment Covered in the On-Body Drug Delivery Devices Market:
By Devices Type (Wearable Injectors, Infusion Pumps, Others)
By Molecule Type (Small Molecule, Large Molecule)
By Application (Cardiovascular Diseases, Cancer, Diabetes, Auto-immune Disease, Others)
By Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription?sg
Recent Developments in the On-Body Drug Delivery Devices Market
✅ December 2024 - Aptar Digital Health partnered with Gerresheimer to launch an integrated solution for cancer treatment. By linking Aptar's proprietary SaDM (Software as a Device Management) platform with Gerresheimer's Gx SensAir-an advanced on-body device designed for the subcutaneous administration of large-molecule biologics-the collaboration aims to enhance treatment adherence and improve patient outcomes in oncology care.
✅ February 2024 - Tandem Diabetes Care introduced the Tandem Mobi, the world's smallest automated insulin delivery system in the U.S. This innovative device is fully operable via smartphone and integrates seamlessly with the Dexcom G7 continuous glucose monitor. The launch represents a significant advancement in wearable diabetes management technology, enabling users to discreetly manage insulin delivery with increased flexibility and control.
Regional Analysis for On-Body Drug Delivery Devices Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Most Frequently Asked Questions in the On-Body Drug Delivery Devices Market Research Industry:
➠ Who leads the On-Body Drug Delivery Devices industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do On-Body Drug Delivery Devices market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting On-Body Drug Delivery Devices market growth?
➠ What are the dominant sales and distribution strategies in the On-Body Drug Delivery Devices industry?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release On-Body Drug Delivery Devices Market is projected to reach US$ 82.74 billion by 2033 | Coherus BioSciences Inc, Tandem Diabetes Care Inc, Battelle, Stevanato Group, NOVO Engineering here
News-ID: 4100960 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Meat Nutrient Composition Analysis Equipment Market Outlook Worldwide By 2031 | …
Global Meat Nutrient Composition Analysis Equipment Market reached US$ 2.44 billion in 2022 and is expected to reach US$ 3.74 billion by 2031, growing with a CAGR of 5.5% during the forecast period 2024-2031.
The Meat Nutrient Composition Analysis Equipment Market Report by DataM Intelligence delivers comprehensive insights into key market trends, growth drivers, and emerging challenges. With a focus on providing actionable intelligence, DataM Intelligence enables businesses to make informed…
Crash Barrier Systems Market | Enhancing Road Safety with Impact Protection | To …
The Global Crash Barrier Systems Market reached USD 7.9 billion in 2022 and is expected to reach USD 10.6 billion by 2030, growing with a CAGR of 3.8% during the forecast period 2024-2031.
The Crash Barrier Systems Market receives exhaustive analysis from DataM Intelligence, delivering stakeholders essential market data, emerging industry patterns, and strategic business intelligence. This in-depth research explores the competitive landscape in detail, evaluating market leaders across multiple dimensions…
Laser Eye Shield Market is projected to grow to US$ 8.03 billion by 2033 | Innov …
The Laser Eye Shield Market was valued at US$ 2.16 billion in 2024 and is projected to grow to US$ 8.03 billion by 2033, registering a compound annual growth rate (CAGR) of 15.8% during the forecast period from 2025 to 2033.
DataM Intelligence's Laser Eyeshield Market report offers in-depth insights into the latest market trends, potential growth areas, and evolving industry challenges. Focused on delivering practical and strategic intelligence, DataM Intelligence…
Global Lutein Food Market Expands US$ 620.2 Mn by 2031 | Kemin Industries, BASF …
Global Lutein Food Market reached US$ 392.1 million in 2023 and is expected to reach US$ 620.2 million by 2031, growing with a CAGR of 5.9% during the forecast period 2024-2031.
The Lutein Food Market Report by DataM Intelligence delivers comprehensive insights into key market trends, growth drivers, and emerging challenges. With a focus on providing actionable intelligence, DataM Intelligence enables businesses to make informed strategic decisions and maintain a competitive…
More Releases for Device
Global Watch Clock Measuring Device Market | Watch Clock Measuring Device Indust …
Watch, clock and measuring device market comprises of the sales of watch, clock, measuring device & related services to measure the time and physical quantity. Watch is portable timepiece, which is worn by people around the wrist, attached by a strap. Clock is a device used to measure and indicate time, using the pointers moving over a dial. Measuring device is an instrument used for measuring the various parameters in…
PC-Based Resting Electrocardiograph Market Value Share, Analysis and Segments 20 …
Cardiovascular diseases are a leading cause of death all over the world, and hence need to be treated as soon as possible after their diagnosis. PC-based ECG machines are one of the most reliable machines that can used to detect, diagnose, and capture highly useful data, which can be used for initiating relevant treatment procedures. Thanks to the various benefits provided by these devices, a distinct PC-based electrocardiograph market exists…
Peripheral Vascular Device Market Size, Peripheral Vascular Device Market Share, …
Global Peripheral Vascular Device Market Size is observed to gain traction owing to the factors such as increasing research and development for developing several new product, and rising funding by the private organizations.
Request for Sample of This Research Report @ https://bit.ly/2xjOKpC
Top Key Player:-
Abbott Laboratories
Braun Melsungen AG
Boston Scientific Corporation
R. Brad, Inc.
Cardinal Health, Inc.
Medtronic plc.
Cook Medical, Inc.
Teruma Corporation
Jude Medical, Inc.
The Spectranetics Corporation
Volcano Corporation
Peripheral vascular disorder (PVD) is a blood circulation disorder…
Medical Device Technologies Market - The Evolution of Medical Device Technologie …
The global medical device technologies market is anticipated to be boosted by various well-known players in the market. Some of these players that are dealing with the manufacturing of in vitro diagnostic devices hold a significant share in the global market. Whereas, the small market players are emerging from several developing nations, looking to set their foot in the market. Such measures are foreseen to change the market scenario in…
Energy Based Device in Hyperhidros Market Report 2018: Segmentation by Product ( …
Global Energy Based Device in Hyperhidros market research report provides company profile for Alma Lasers, ThermiAesthetics, Ulthera, Valeant, Cynosure, Miramar Lab, Fotona and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also…
Timing Device Market
Asia Pacific traffic sensor market is expected to hold the majority share due to the adoption of technologically-advanced systems. Growing urban population and the increasing need for real-time information systems in the region will propel the traffic sensor market growth. Growing urban population in countries including India, China, Japan, and South Korea is increasing the strain on the traffic management solutions. This is encouraging the governments to invest increasingly in…
